Treatment of hypersplenism in patients with portal hypertension of hepatic cirrhosis
10.3760/cma.j.issn.1007-8118.2018.02.019
- VernacularTitle:肝硬化门静脉高压症患者脾功能亢进的治疗
- Author:
Weiyang HE
1
;
Yanfeng WANG
;
Yan XIONG
;
Qifa YE
Author Information
1. 430071,武汉大学中南医院武汉大学肝胆疾病研究院武汉大学移植医学中心移植医学技术湖北省重点实验室
- Keywords:
Hypersplenism;
Splenectomy;
Partial splenic embolization;
Liver transplantation
- From:
Chinese Journal of Hepatobiliary Surgery
2018;24(2):133-135
- CountryChina
- Language:Chinese
-
Abstract:
Hypersplenism is a common clinical manifestation of portal hypertension in hepatic cirrhosis.Clinical treatment of hypersplenism includes splenectomy,partial splenic embolization and liver transplantation.Splenectomy and partial splenic embolization are effective for hypersplenism,but the main complications are portal / splenic vein thrombosis (PSVT) and infection.Liver transplantation is an ideal method for the treatment of hypersplenism caused by cirrhosis,but patients with liver transplantation may still have persistent hypersplenism.Simultaneous splenectomy or partial splenic embolization which is performed with liver transplantation is a therapy of persistent hypersplenism.It can improve the function of graft but also increase the risk of infection.
